An A1C of 4.7% falls within the range considered normal for adults without diabetes and is not, by itself, a cause for concern. The standard reference range runs from about 4.0% to 5.6%, with values between 5.7% and 6.4% suggesting prediabetes and 6.5% or higher pointing to diabetes. But “normal” does not always mean “accurate,” and context matters enormously. A person without diabetes who has always run an A1C around 4.7% is in a very different situation from a person with diabetes whose A1C has dropped to 4.7% while on medication, or someone whose blood sugar readings seem higher than a 4.7% result would suggest.
When 4.7% Is Perfectly Fine
If you do not have diabetes, are not taking blood-sugar-lowering medications, and your doctor ordered an A1C as part of routine screening, a result of 4.7% is unremarkable. It suggests your average blood sugar over the past two to three months has been well within the healthy range. Many healthy adults sit between 4.5% and 5.5% without any intervention at all. There is no clinical threshold at which an A1C becomes “too good” in a healthy person, and pursuing a lower number is not a medical goal.
The picture changes when something else in your lab work or symptoms does not line up with that number. If your fasting glucose runs higher than expected, if you have symptoms of low blood sugar (shakiness, confusion, sweating after skipping a meal), or if you have a known blood disorder, a 4.7% result deserves a closer look, not because the number itself is dangerous, but because the reading may not reflect what is actually happening with your blood sugar.
Why an A1C Can Read Lower Than Expected
A1C measures how much glucose has attached to hemoglobin inside your red blood cells. The test assumes your red blood cells live for roughly 120 days and that your hemoglobin behaves in the standard way. When either assumption breaks down, the number the lab reports can drift away from your true average glucose. Several conditions push A1C readings artificially low.
Shorter Red Blood Cell Lifespan
Anything that causes red blood cells to die off faster than usual means hemoglobin spends less time in circulation picking up glucose, and the A1C reads lower than your actual glucose levels would predict. A shorter red blood cell lifespan reduces the total amount of glycated hemoglobin simply because the cells are not around long enough to accumulate it.1PubMed Central. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7% Conditions that shorten red cell life include hemolytic anemias, sickle cell disease, thalassemia, chronic blood loss, and even spleen enlargement. If you have been told you have anemia and your A1C seems surprisingly low, the two findings may be directly connected.
Recent Blood Loss or Transfusion
Significant blood loss, whether from surgery, heavy menstrual periods, gastrointestinal bleeding, or blood donation, flushes out older red blood cells and replaces them with younger ones that have not yet had time to accumulate much glucose on their hemoglobin. The result is a lower A1C that does not match your day-to-day glucose readings. A study of patients who donated their own blood before elective surgery found that A1C decreased in all 24 participants after donation.2PubMed Central. Alterations in HbA1c resulting from the donation of autologous blood for elective surgery in patients with diabetes mellitus
Blood transfusions produce a similar effect. Donor red blood cells come from people with presumably normal glucose levels, so receiving a transfusion dilutes your own glycated hemoglobin with cells carrying less glucose. In one study, the average A1C drop across transfused patients with diabetes was about 0.8 percentage points, and for those whose starting A1C was above 7%, the average decrease was closer to two full points.3Clinical Chemistry. Red Cell Transfusion Decreases Hemoglobin A1c in Patients with Diabetes That is a massive shift from a single event that has nothing to do with actual glucose control. People with transfusion-dependent conditions like thalassemia face this problem chronically, making A1C an unreliable marker for them altogether.4PubMed Central. Estimation of HbA1c Levels in Transfusion-Dependent Thalassemia Patients in Comparison With Normal Healthy Individuals
Hemoglobin Variants
If you carry a variant form of hemoglobin, such as hemoglobin S (sickle cell trait), hemoglobin C, hemoglobin D, or elevated fetal hemoglobin, the lab method used to measure your A1C may produce an inaccurate result. Some variants cause the reading to come back falsely low, others falsely high, and it depends heavily on which laboratory technique is used.5PubMed Central. A review of variant hemoglobins interfering with hemoglobin A1c measurement Hemoglobin variants can interfere with common measurement methods including ion exchange chromatography, capillary electrophoresis, and immunoassays.6PubMed. Interference of hemoglobin variants in HbA(1c) quantification
One study screening over 42,000 samples found abnormal results in 160, and for several hemoglobin types (including Hb D and Hb Louisville), the A1C reported by one lab method did not match the patient’s fasting glucose at all. Switching to a different measurement method corrected the result in most cases.7PubMed Central. Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method The practical takeaway is that if your A1C seems unusually low (or high) and you have known hemoglobin traits or come from a population where variants are common, it is worth asking whether the lab used a method susceptible to interference.
Liver Disease
Advanced liver disease, particularly decompensated cirrhosis, can push A1C readings lower than expected through several routes. Patients with cirrhosis frequently develop anemia from chronic gastrointestinal bleeding, portal hypertension, hypersplenism (where an enlarged spleen destroys red blood cells faster than normal), and the direct bone marrow effects of alcohol or antiviral medications. All of these shorten red cell lifespan or reduce hemoglobin levels, pulling A1C down in a way that does not reflect glucose control. Research on patients with decompensated cirrhosis found that A1C is not a reliable predictor of glycemic control in this group, especially when severe anemia is present.8PubMed Central. Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
On the other end of the liver-kidney spectrum, some evidence suggests that liver disease and chronic kidney disease can also raise A1C in certain patients, depending on the specific condition and its stage.9PubMed. Association between liver and chronic kidney disease on hemoglobin A1c concentrations The direction of the error depends on the type and severity of organ dysfunction, which is precisely why clinicians dealing with these populations pay close attention to whether A1C still tracks with other glucose markers.
Overtreatment in People with Diabetes
For someone with type 2 diabetes taking medication, an A1C of 4.7% raises a different question entirely: not whether the reading is accurate, but whether the treatment is pushing blood sugar dangerously low. Tight glucose control protects against long-term complications, but driving A1C below 7% with insulin, sulfonylureas, or glinides introduces real risks of hypoglycemia, especially in older adults.
A population-level study of people aged 75 and older with type 2 diabetes found that over a quarter of those on high-risk drugs like insulin, sulfonylureas, or glinides had A1C values below 7%, raising the possibility of overtreatment. Among those specifically on sulfonylureas, nearly half had A1C below 7%.10PubMed Central. Potential Risk of Overtreatment in Patients with Type 2 Diabetes Aged 75 Years or Older: Data from a Population Database in Catalonia, Spain Sulfonylureas as a class carry a higher risk of hypoglycemia compared with other diabetes medications.11PubMed Central. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
If you are managing diabetes and your A1C has fallen to 4.7%, this does not mean your diabetes is “cured” or that you are doing exceptionally well. It may mean your medication doses need to be reduced. Recurrent low blood sugar episodes can cause falls, confusion, heart rhythm disturbances, and in severe cases, loss of consciousness. The benefit of tight control diminishes with age, and guidelines for older adults generally suggest A1C targets in the 7% to 8% range when medications that can cause lows are involved. Talk to your prescriber before adjusting anything yourself, but a 4.7% reading is worth flagging.
The U-Shaped Mortality Curve
There is a somewhat unsettling finding in the epidemiological literature: very low A1C values are associated with higher mortality, even in people without diabetes. Studies of older adults with diabetes have described a U-shaped relationship, where both high and low A1C levels correspond to increased risk of death.12PubMed Central. Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor? And in a large nationally representative analysis of adults without diabetes, an A1C below 4.0% was tied to roughly triple the risk of death from any cause compared with a level between 5.0% and 5.4%, even after adjusting for lifestyle factors, cardiovascular risk, red blood cell indices, and liver function.13PubMed Central. Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes
Before this sends you spiraling, note the threshold: the sharply increased risk kicks in below 4.0%, not at 4.7%. At 4.7%, you are comfortably above that cutoff. The broader point, though, is that a very low A1C in someone who is losing weight unintentionally, dealing with chronic illness, or showing signs of malnutrition may not be a sign of healthy glucose metabolism. It may be a marker of an underlying problem that is driving both the low reading and the increased risk. The researchers in that field have debated whether frailty itself explains the mortality link, since frail, malnourished individuals eat less and therefore run lower glucose levels, while also being at higher risk of dying for many reasons.
Racial and Ethnic Differences in A1C
A1C does not map to average blood glucose in exactly the same way for everyone. Research has documented racial and ethnic differences in the relationship between glucose and A1C that go beyond differences in diabetes prevalence. For a given glucose level, Black individuals tend to have higher A1C readings than white individuals, by about 0.4 percentage points on average.14PubMed. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels Put differently, the same A1C value of 4.7% might correspond to a somewhat lower actual average glucose in a Black person compared with a white person.
The reasons for these differences are not fully understood. Possibilities being explored include variations in red blood cell lifespan, differences in how glucose moves across red cell membranes, and genetic factors that affect the rate at which hemoglobin becomes glycated, independent of blood glucose levels.15PubMed Central. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes This is an area where the science is genuinely incomplete, but the practical implication matters: A1C-based diagnostic cutoffs may not work equally well across all populations, and a 4.7% reading may correspond to meaningfully different average glucose levels in different people.
Genetics and the Rate of Hemoglobin Glycation
Beyond hemoglobin variants and red cell lifespan, there are genetic factors that directly influence how quickly glucose attaches to hemoglobin. One studied example involves fructosamine-3-kinase (FN3K), an enzyme that removes sugar molecules from proteins, including hemoglobin. People carry different versions of the FN3K gene, and the variant you have affects your baseline A1C. In one study, people with diabetes who carried the CC variant of a specific FN3K gene polymorphism had notably lower A1C levels (averaging about 6.5%) compared with those carrying the GC or GG variants (who averaged closer to 7.7%), despite similar glucose profiles.16PubMed Central. A polymorphism within the fructosamine-3-kinase gene is associated with HbA1c Levels and the onset of type 2 diabetes mellitus
This means that some people are natural “low glycators” whose hemoglobin simply does not accumulate glucose as readily, producing consistently lower A1C readings even when their blood sugar is the same as someone else’s. If you have always had A1C values on the lower end without any medical explanation, this genetic variation may be part of the reason. It is not clinically actionable in the sense that doctors rarely test for FN3K variants, but it is worth knowing that “your number” is partly determined by biology you did not choose.
When A1C and Glucose Readings Do Not Match
One of the most common reasons people start questioning a 4.7% A1C is that their finger-stick readings or continuous glucose monitor data seem to tell a different story. Maybe your fasting glucose runs in the mid-90s or your post-meal spikes look higher than a 4.7% average would predict. That disconnect is actually well documented. Even in populations without any known confounders, the relationship between A1C and average glucose is imperfect. At an A1C of 6.0%, for example, the estimated mean blood glucose has a wide confidence interval spanning from 100 to 152 mg/dL.17Diabetes Care. When the Blood Glucose and the HbA1c Don’t Match: Turning Uncertainty Into Opportunity At lower A1C levels like 4.7%, the spread is similarly broad.
Three main explanations account for this mismatch: glucose swings that your occasional finger-stick readings miss, technical measurement variability in either the glucose or A1C test itself, and genuine biological differences in how readily your hemoglobin becomes glycated. The first two are measurement noise. The third is a real biological signal that A1C is reflecting something other than just your average glucose.
Alternative Markers When A1C Is Not Reliable
If your doctor suspects your A1C reading is being skewed by one of the conditions described above, several alternative biomarkers can step in to assess glucose control. The two most commonly used are fructosamine and glycated albumin.
Fructosamine measures glucose attached to serum proteins (mostly albumin) rather than hemoglobin. Because albumin turns over faster than red blood cells, fructosamine reflects average glucose over roughly two to three weeks instead of two to three months. Glycated albumin is a more specific version of the same idea. Both are unaffected by red blood cell lifespan, hemoglobin variants, or transfusions, which makes them useful in exactly the situations where A1C falls short. Of the two, glycated albumin appears to perform better across a broader range of clinical settings.18PubMed Central. Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes
Another option is 1,5-anhydroglucitol (often abbreviated 1,5-AG), a naturally occurring sugar whose blood level drops when glucose is running high. It is particularly sensitive to recent glucose spikes, making it a useful complement to A1C’s long-term average. All three of these markers are recognized as alternatives when A1C values are difficult to interpret.19PubMed Central. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol Continuous glucose monitoring is yet another approach, capturing actual glucose values every few minutes and removing the estimation step entirely.
Practical Steps If You Are Wondering About Your 4.7%
Your response to a 4.7% A1C should depend entirely on your clinical context. Consider these scenarios:
- Healthy, no medications: A 4.7% is normal. No action needed unless your doctor sees something else in your labs worth investigating.
- On diabetes medications: Ask your doctor whether your regimen is pushing blood sugar too low. If you are on insulin, sulfonylureas, or glinides, overtreatment is a real possibility, especially if you are older or have kidney issues.
- Known anemia or blood disorder: Your A1C may be reading artificially low. Request a glycated albumin or fructosamine test to cross-check.
- Recent blood loss, surgery, or transfusion: Expect a temporarily depressed A1C. Wait at least three months after your red blood cells have had time to turn over before trusting a new A1C result.
- Glucose readings seem higher than 4.7% implies: Bring those readings to your doctor. A mismatch between A1C and home glucose data is a recognized clinical scenario, and further evaluation can determine the cause.
Endocrine Conditions That Lower Blood Sugar
In rare cases, a low A1C is not an artifact at all. It accurately reflects genuinely low blood sugar caused by an underlying endocrine problem. Insulinomas, which are small tumors of the insulin-producing cells in the pancreas, can cause persistent and sometimes severe hypoglycemia. Adrenal insufficiency, where the adrenal glands do not produce enough cortisol, can also lead to low blood sugar because cortisol normally helps maintain glucose levels between meals. These conditions are uncommon, but they can produce dramatic symptoms: episodes of confusion, fainting, rapid heartbeat, and shakiness, particularly during fasting or overnight.
A case report involving a patient with repeated severe hypoglycemic episodes (blood sugar dropping below 35 mg/dL despite intravenous glucose) illustrates how these diagnoses can be difficult to sort out. That patient’s A1C was 4.8%, and the clinical team had to work through multiple endocrine tests to distinguish between an insulinoma and adrenal insufficiency as the underlying cause.20PubMed Central. A Hypoglycemic Crisis: Insulinoma or Adrenal Insufficiency? If your low A1C accompanies symptoms of hypoglycemia that you cannot explain by diet or medication, an endocrine workup is the appropriate next step. These conditions are rare enough that most people reading this article will not have them, but serious enough that they should not be dismissed.